Evidence for in vitro and in vivo activity of the antimalarial pyronaridine against Schistosoma.
<h4>Background</h4>Schistosomiasis is highly prevalent in Africa. Praziquantel is effective against adult schistosomes but leaves prepatent stages unaffected-which is a limit to patient management and elimination. Given the large-scale use of praziquantel, development of drug resistance...
Saved in:
Main Authors: | Erik Koehne (Author), Nina Zander (Author), Miriam Rodi (Author), Jana Held (Author), Wolfgang Hoffmann (Author), Rella Zoleko-Manego (Author), Michael Ramharter (Author), Ghyslain Mombo-Ngoma (Author), Peter G Kremsner (Author), Andrea Kreidenweiss (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Evidence for in vitro and in vivo activity of the antimalarial pyronaridine against Schistosoma.
by: Erik Koehne, et al.
Published: (2022) -
Correction: Evidence for in vitro and in vivo activity of the antimalarial pyronaridine against Schistosoma
by: Erik Koehne, et al.
Published: (2022) -
Effectiveness of antimalarial drug combinations in treating concomitant urogenital schistosomiasis in malaria patients in Lambaréné, Gabon: A non-randomised event-monitoring study.
by: Rella Zoleko-Manego, et al.
Published: (2022) -
Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infection.
by: Thomas R Lane, et al.
Published: (2019) -
Repurposing Antimalarial Pyronaridine as a DNA Repair Inhibitor to Exploit the Full Potential of Gold-Nanoparticle-Mediated Radiation Response
by: Nolan Jackson, et al.
Published: (2022)